Hemostemix Historical Cash Flow
| HEM Stock | CAD 0.08 0.01 11.11% |
Analysis of Hemostemix cash flow over time is an excellent tool to project Hemostemix future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 1.4 M or Stock Based Compensation of 142.4 K as it is a great indicator of Hemostemix ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hemostemix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hemostemix is a good buy for the upcoming year.
Hemostemix |
About Hemostemix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hemostemix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hemostemix's non-liquid assets can be easily converted into cash.
Hemostemix Cash Flow Chart
Add Fundamental
Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Depreciation
Depreciation indicates how much of Hemostemix value has been used up. For tax purposes Hemostemix can deduct the cost of the tangible assets it purchases as business expenses. However, Hemostemix must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Hemostemix's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hemostemix current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemostemix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Hemostemix's Sale Purchase Of Stock is fairly stable compared to the past year. Change In Cash is likely to climb to about 20.7 K in 2024, whereas Stock Based Compensation is likely to drop slightly above 142.4 K in 2024.
Hemostemix cash flow statement Correlations
Click cells to compare fundamentals
Hemostemix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hemostemix cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (1.4M) | 233.9K | (38.5K) | (83.7K) | 19.7K | 20.7K | |
| Stock Based Compensation | 333.3K | 2.3M | 361.6K | 178.7K | 149.9K | 142.4K | |
| Free Cash Flow | (3.4M) | (6.0M) | (3.5M) | (6.1M) | (1.5M) | (1.6M) | |
| Change In Working Capital | 1.0M | (825.7K) | 2.8M | (1.7M) | 554.7K | 491.2K | |
| Begin Period Cash Flow | 1.5M | 24.1K | 258.0K | 219.4K | 135.7K | 129.0K | |
| Other Cashflows From Financing Activities | 3.9M | 1.4M | 2.6M | 5.3M | (78.1K) | (74.2K) | |
| Other Non Cash Items | 105.0K | 106.0K | (114.3K) | 172.8K | 335.9K | 352.7K | |
| Total Cash From Operating Activities | (3.4M) | (6.0M) | (3.5M) | (6.1M) | (1.5M) | (1.6M) | |
| Change To Account Receivables | 115.5K | (2.0M) | 1.7M | 203.8K | 113.9K | 119.6K | |
| Change To Operating Activities | 1.2M | 40.5K | (2.0M) | 13.5K | 12.2K | 12.8K | |
| Net Income | (4.9M) | (7.8M) | (6.3M) | (5.2M) | (2.5M) | (2.6M) | |
| Total Cash From Financing Activities | 2.0M | 6.2M | 3.3M | 6.0M | 1.5M | 1.4M | |
| End Period Cash Flow | 24.1K | 258.0K | 219.4K | 135.7K | 155.4K | 147.6K | |
| Change To Netincome | 1.6M | 438.2K | 2.6M | 838.4K | 964.1K | 1.0M | |
| Change To Liabilities | 910.7K | 1.2M | 0.0 | (1.7M) | (1.5M) | (1.5M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.